Reply to external validation of a model to predict local failure after radical cystectomy

By  

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3585-3585

Blackwell Publishing

Access to resources Recommend Favorite

Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710

By Christodouleas John P.   Baumann Brian C.   He Jiwei   Hwang Wei-Ting   Tucker Kai N.   Bekelman Justin E.   Tangen Catherine M.   Lerner Seth P.   Guzzo Thomas J.   Malkowicz S. Bruce  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1272-1280

Blackwell Publishing

Access to resources Recommend Favorite

Erratum: Christodouleas JP, Baumann BC, He J, Hwang W-T, Tucker KN, Bekelman JE, Tangen CM, Lerner SP, Guzzo TJ and Malkowicz SB. Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710 Cancer. 2014;120:1272-80

By  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 162-162

Blackwell Publishing

Access to resources Recommend Favorite

Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer

By Hu Michael   Jacobs Bruce L.   Montgomery Jeffrey S.   He Chang   Ye Jun   Zhang Yun   Brathwaite Julien   Morgan Todd M.   Hafez Khaled S.   Weizer Alon Z.   Gilbert Scott M.   Lee Cheryl T.   Lavieri Mariel S.   Helm Jonathan E.   Hollenbeck Brent K.   Skolarus Ted A.  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1409-1416

Blackwell Publishing

Access to resources Recommend Favorite

Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure

By Fransen Jaap   Kooloos Wouter M   Wessels Judith AM   Huizinga Tom WJ   Guchelaar Henk-Jan   van Riel Piet LCM   Barrera Pilar  

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1087-1094

Future Medicine

Access to resources Recommend Favorite